GlassScriptPhysician profile
Abby H Gallagher
NPI 1043652472
$1,523.47
in general payments reported to CMS, 2019-2025
22 companies · $454 in 2025
The $454 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $343 · 2022: $160 · 2023: $98.40 · 2024: $469 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $332.68 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $218.73 | 2021-2025 | Nucala, Trelegy Ellipta |
| United Therapeutics Corporation | $158.09 | 2024-2025 | |
| Grifols USA, LLC | $107.06 | 2023-2025 | Prolastin-C Liquid |
| Amgen INC. | $102.11 | 2021-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $80.86 | 2021-2025 | Ofev, Jascayd |
| Jazz Pharmaceuticals INC. | $71.43 | 2021-2025 | |
| Insmed, INC. | $51.62 | 2021-2025 | Brinsupri, Arikayce |
| Merck Sharp & Dohme LLC | $50.86 | 2024 | Keytruda |
| Inspire Medical Systems, INC. | $48.35 | 2024-2025 | Inspire |
| Harmony Biosciences LLC | $41.86 | 2022-2023 | Wakix |
| Verona Pharma, INC. | $40.47 | 2025 | Ohtuvayre |
| Regeneron Healthcare Solutions, INC. | $36.01 | 2022-2024 | Dupixent |
| Philips North America LLC | $30.68 | 2025 | Vest Therapy Und |
| Pfizer INC. | $27.53 | 2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avadel Cns Pharmaceuticals, LLC | $24.47 | 2024 | Lumryz |
| Actelion Pharmaceuticals US, INC. | $21.08 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.45 | 2023 | Glassia |
| Lilly USA, LLC | $16.03 | 2025 | Zepbound |
| Baxter Healthcare | $15.42 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Janssen Pharmaceuticals, INC | $15.17 | 2022 | |
| Pulmonx Corporation | $13.51 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abby Gallagher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.